ArticleOncology letters2017

Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare

Pawel Krawczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.